全球自體免疫疾病診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計自體免疫疾病診斷市場將從 2025 年的 67.4 億美元成長到 2034 年的 153 億美元，2026 年至 2034 年的複合年成長率為 9.54%。

受自體免疫疾病盛行率上升和診斷技術進步的推動，自體免疫免疫疾病診斷市場預計將顯著成長。隨著人們對自體免疫自體免疫疾病的認知不斷提高，醫療機構越來越重視早期發現和精準診斷，以改善患者預後。酵素免疫分析法(ELISA)、多重檢測和次世代定序等實驗室技術的創新正在提高診斷測試的靈敏度和特異性。這些進步使臨床醫生能夠識別多種自體免疫疾病，包括類風濕性關節炎、狼瘡和多發性硬化症，有助於制定及時有效的治療策略。

此外，個人化醫療的日益普及正在影響自體免疫疾病的診斷市場。基於個別患者特徵和基因標記制定治療方案正變得越來越可行，從而實現更有效、更有針對性的干涉。人工智慧 (AI) 和機器學習在診斷過程中的應用也在不斷推進，使這些技術能夠分析複雜的資料集、識別模式並預測疾病進展。這種向數據驅動型診斷的轉變有望提高自體免疫疾病檢測的準確性並改善患者管理。

此外，就地檢驗的興起正在改變自體免疫疾病診斷的模式。快速且方便的檢測方式在臨床實務中變得至關重要，使醫療專業人員能夠迅速做出明智的決策。這一趨勢在偏遠地區和缺乏專業診斷設施及醫療資源的地區尤其重要。總之，在技術創新、個人化診療方案以及為改善複雜自體免疫疾病患者的患者照護而做出的努力的推動下，自體免疫疾病診斷市場預計將迎來強勁成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球自體免疫疾病診斷市場：依產品分類

• 市場分析、洞察與預測
• 耗材和檢測試劑盒
• 裝置

第5章 全球自體免疫疾病診斷市場：依檢測類型分類

• 市場分析、洞察與預測
• 常規檢測
• 發炎標記物
• 自體抗體和免疫學檢測
• 其他

第6章 全球自體免疫疾病診斷市場：依疾病分類

• 市場分析、洞察與預測
• 類風濕性關節炎
• 全身性紅斑性狼瘡
• 修格蘭氏症候群
• 甲狀腺炎
• 硬皮症
• 其他

第7章 全球自體免疫疾病診斷市場：依最終用戶分類

• 市場分析、洞察與預測
• 臨床檢查室
• 醫院
• 其他

第8章 全球自體免疫疾病診斷市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific
  • Siemens
  • Abbott
  • Danaher
  • Bio-Rad Laboratories
  • Grifols
  • Trinity Biotech
  • Werfen
  • HYCOR Biomedical
  • EUROIMMUN AG
  • Oncimmune
  • HTG Molecular Diagnostics
  • Seramun Diagnostica GmbH
  • Exagen Inc
  • Cambridge Life Sciences Limited

The Autoimmune Disease Diagnostics Market size is expected to reach USD 15.30 Billion in 2034 from USD 6.74 Billion (2025) growing at a CAGR of 9.54% during 2026-2034.

The autoimmune disease diagnostics market is poised for significant growth, driven by the increasing prevalence of autoimmune disorders and advancements in diagnostic technologies. As awareness of autoimmune diseases rises, healthcare providers are increasingly focusing on early detection and accurate diagnosis to improve patient outcomes. Innovations in laboratory techniques, such as enzyme-linked immunosorbent assays (ELISA), multiplex assays, and next-generation sequencing, are enhancing the sensitivity and specificity of diagnostic tests. These advancements enable clinicians to identify a wide range of autoimmune conditions, including rheumatoid arthritis, lupus, and multiple sclerosis, facilitating timely and effective treatment strategies.

Moreover, the growing emphasis on personalized medicine is influencing the autoimmune disease diagnostics market. Tailoring treatment plans based on individual patient profiles and genetic markers is becoming increasingly feasible, allowing for more effective and targeted interventions. The integration of artificial intelligence and machine learning in diagnostic processes is also gaining traction, as these technologies can analyze complex data sets to identify patterns and predict disease progression. This shift towards data-driven diagnostics is expected to enhance the accuracy of autoimmune disease detection and improve patient management.

Additionally, the rise of point-of-care testing is transforming the landscape of autoimmune diagnostics. Rapid and convenient testing options are becoming essential in clinical settings, enabling healthcare providers to make informed decisions quickly. This trend is particularly relevant in remote and underserved areas, where access to specialized diagnostic facilities may be limited. In summary, the autoimmune disease diagnostics market is set for robust growth, characterized by technological innovation, personalized approaches, and a commitment to improving patient care in the face of complex autoimmune conditions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables & Assay Kits
• Instruments

By Test Type

• Routine Laboratory Tests
• Inflammatory Markers
• Autoantibodies & Immunologic Test
• Other

By Disease

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• SjAfA¶gren's Syndrome
• Thyroiditis
• Scleroderma
• Other

By End User

• Clinical Laboratories
• Hospitals
• Other

COMPANIES PROFILED

• Thermo Fisher Scientific, Siemens, Abbott, Danaher, BioRad Laboratories, Grifols, Trinity Biotech, Werfen, HYCOR Biomedical, EUROIMMUN AG, Oncimmune, HTG Molecular Diagnostics, Seramun Diagnostica GmbH, Exagen Inc, Cambridge Life Sciences Limited

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables & Assay Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Routine Laboratory Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Inflammatory Markers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Autoantibodies & Immunologic Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY DISEASE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Disease
• 6.2. Rheumatoid Arthritis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Systemic Lupus Erythematosus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. SjAfA¶gren's Syndrome Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Thyroiditis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Scleroderma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Test Type
  • 8.2.3 By Disease
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Test Type
  • 8.3.3 By Disease
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Test Type
  • 8.4.3 By Disease
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Test Type
  • 8.5.3 By Disease
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Test Type
  • 8.6.3 By Disease
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific
  • 10.2.2 Siemens
  • 10.2.3 Abbott
  • 10.2.4 Danaher
  • 10.2.5 Bio-Rad Laboratories
  • 10.2.6 Grifols
  • 10.2.7 Trinity Biotech
  • 10.2.8 Werfen
  • 10.2.9 HYCOR Biomedical
  • 10.2.10 EUROIMMUN AG
  • 10.2.11 Oncimmune
  • 10.2.12 HTG Molecular Diagnostics
  • 10.2.13 Seramun Diagnostica GmbH
  • 10.2.14 Exagen Inc
  • 10.2.15 Cambridge Life Sciences Limited